Berberine is used to treat gastrointestinal infections, diabetes, high blood pressure, and cholesterol. Many studies report interactions between berberine-containing products and cytochrome P450, but little is known about whether berberine alters CYP activities in humans. Researchers at the Xiang Ya School of Medicine, in the People’s Republic of China, studied the effects of berberine on … Continue reading Potential for berberine to cause drug interactions →
Researchers from the David Geffen School of Medicine, at the University of California, in Los Angeles have reviewed the evidence.
Recently, the American Academy of Pediatrics published guidelines for screening children for high cholesterol blood levels. Now, researchers from the Centers for Disease Control and Prevention in Atlanta, Georgia have estimated the number that might need treatment.
It appears to have positive effects in both conditions, according to this study by researchers at Min-Hang Hospital in Shanghai.
November is diabetes month at the CAM Report. Here’s what we covered so far this year.
The Centers for Disease Control has just published the latest data on the prevalence of diabetes in the US. 11% of adults aged 40 to 59 years 23% of those 60 and older have diabetes Is it any wonder that so many CAM therapies are studied in people with diabetes? A quick listing of CAM … Continue reading Prevalence of diabetes in the US in 2006 →
Preliminary evidence, in the August issue of Diabetes indicates that “berberine displays beneficial effects in the treatment of diabetes and obesity at least in part via stimulation of AMPK [AMP-activated protein kinase] activity.” Here’s some background.
Complementary and Alternative Medicine: Fair, Balanced, and to the Point